- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/705 - ReceptorsCell surface antigensCell surface determinants
Patent holdings for IPC class C07K 14/705
Total number of patents in this class: 15711
10-year publication summary
|
925
|
1166
|
1288
|
1385
|
1568
|
1539
|
1453
|
1359
|
1168
|
627
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20745 |
338 |
| The Trustees of the University of Pennsylvania | 4415 |
333 |
| The Board of Trustees of the Leland Stanford Junior University | 6653 |
214 |
| Regeneron Pharmaceuticals, Inc. | 4701 |
201 |
| Memorial Sloan-Kettering Cancer Center | 2043 |
198 |
| Board of Regents, The University of Texas System | 6107 |
168 |
| Novartis AG | 10262 |
148 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3001 |
146 |
| Immatics Biotechnologies GmbH | 1127 |
140 |
| The General Hospital Corporation | 4870 |
99 |
| Dana-Farber Cancer Institute, Inc. | 2664 |
92 |
| Autolus Limited | 267 |
85 |
| Alpine Immune Sciences, Inc. | 87 |
82 |
| City of Hope | 1030 |
82 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 1021 |
78 |
| Baylor College of Medicine | 1002 |
76 |
| CRISPR Therapeutics AG | 367 |
73 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3335 |
72 |
| Lentigen Technology, Inc. | 107 |
72 |
| The Johns Hopkins University | 5882 |
71 |
| Other owners | 12943 |